Literature DB >> 65127

Evidence for an active immune response in acute hyperthyroidism (Graves' disease).

P I Folb, H Bank.   

Abstract

Activated lymphocytes, identified by an autoradiographic labeling method, were found to be present in the peripheral blood of the majority of 20 patients with acute hyperthyroidism (Graves' disease). The number of such cells in the blood was significantly greater than that found in 30 healthy controls (p less than 0.00001), and in 13 patients who had previously suffered from acute hyperthyroidism, and who were judged to be euthyroid following therapy (p less than 0.025). This latter group included two patients in whom such activated lymphocytes had been found in the blood during the acute phase of their illness. Furthermore, there were significant differences between the number of such activated circulating lymphocytes in the group of patients with acute hyperthyroidism and five patients suffering from hyperthyroidism due to a toxic thyroid nodule (p less than 0.001), five patients suffering from primary myxedema (p less than 0.001), or in 14 patients with a nontoxic multinodular goiter (p less than 0.05). Identification and counting of circulating T and B lymphocytes by fluorescent immunolabeling and rosette-forming techniques in a small number of the patients with acute hyperthyroidism failed to reveal significant differences from the normal. The results suggest that in acute hyperthyroidism there is active stimulation of the cellular immune system, and that this effect is specific to the early, untreated phase of the disease. This response is different to other thyroid diseases, including hyperthyroidism due to a toxic thyroid nodule.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 65127     DOI: 10.1097/00000441-197611000-00004

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  2 in total

1.  Increase of peripheral B lymphocytes in Graves' disease.

Authors:  H Mori; N Amino; Y Iwatani; O Kabutomori; S Asari; S Motoi; K Miyai; Y Kumahara
Journal:  Clin Exp Immunol       Date:  1980-10       Impact factor: 4.330

2.  Encephalomyelitis with thyrotoxicosis.

Authors:  S Bassi; M G Albizzati; A Beltramelli; L Frattola
Journal:  J Neurol       Date:  1978-08-25       Impact factor: 4.849

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.